Pfizer to funnel $500M into biotechs
Bristol-Myers' Zeposia launches into crowded MS market
AstraZeneca gets FDA ok for Brilinta in CAD patients
Merck CEO Frazier urges businesses to help bridge racial equity gap
please scroll down for all the latest news*